Literature DB >> 30615302

Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure.

Christian Nagel1, Alberto M Marra2, Nicola Benjamin3, Norbert Blank4, Antonio Cittadini5, Gerry Coghlan6, Oliver Distler7, Christopher P Denton6, Benjamin Egenlauf3, Christoph Fiehn8, Christine Fischer4, Satenik Harutyunova3, Marius M Hoeper9, Hanns-Martin Lorenz4, Panagiota Xanthouli3, Eduardo Bossone10, Ekkehard Grünig3.   

Abstract

OBJECTIVE: This prospective study was undertaken to evaluate right ventricular function and pulmonary arterial compliance (PAC; ratio of stroke volume to pulse pressure) at rest and during exercise in patients with systemic sclerosis (SSc) with normal mean pulmonary artery pressure (PAP), patients with SSc with mildly elevated mean PAP, and patients with SSc with manifest pulmonary hypertension (PH).
METHODS: Patients with SSc (n = 112) underwent clinical assessment and right-sided heart catheterization at rest and during exercise and were divided into 3 groups according to their resting mean PAP values: normal mean PAP (≤20 mm Hg), mildly elevated mean PAP (21-24 mm Hg), and PH (mean PAP ≥25 mm Hg). Results were compared between groups by analysis of variance followed by post hoc Student's t-test.
RESULTS: Compared to patients with normal mean PAP, patients with mildly elevated mean PAP had a lower 6-minute walking distance (P = 0.008), lower cardiac index (P = 0.027) and higher pulmonary vascular resistance (P = 0.0002) during exercise, and lower PAC at rest (P = 0.016) and different stages of exercise (P = 0.033 for 25W and P = 0.024 for 75W).
CONCLUSION: The results of this study suggest that impaired 6-minute walking distance in SSc patients with mildly elevated mean PAP might be caused by reduced PAC during exercise and reduced right ventricular output reserve, presumably due to impaired coupling between the right ventricle and the pulmonary vasculature. These findings provide further evidence of the clinical relevance of mildly elevated mean PAP in patients with SSc.
© 2019, American College of Rheumatology.

Entities:  

Year:  2019        PMID: 30615302     DOI: 10.1002/art.40814

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  8 in total

1.  The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care.

Authors:  Ahmad Sabbahi; Richard Severin; Cemal Ozemek; Shane A Phillips; Ross Arena
Journal:  Expert Rev Respir Med       Date:  2020-01-03       Impact factor: 3.772

2.  Pulmonary arterial hypertension in systemic sclerosis-when criteria and pathobiology differ.

Authors:  Kristofer Andréasson; Göran Rådegran; Hans Brunnström; Dirk M Wuttge; Roger Hesselstrand
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

3.  sPAP/PAAT Ratio as a New Index of Pulmonary Vascular Load: A Study in Normal Subjects and Ssc Patients with and without PH.

Authors:  Walter Serra; Alfredo Chetta
Journal:  Pathophysiology       Date:  2022-03-15

4.  Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis.

Authors:  Panagiota Xanthouli; Julia Miazgowski; Nicola Benjamin; Ojan Gordjani; Benjamin Egenlauf; Satenik Harutyunova; Rebekka Seeger; Alberto M Marra; Norbert Blank; Hanns-Martin Lorenz; Ekkehard Grünig; Christina A Eichstaedt
Journal:  Arthritis Res Ther       Date:  2022-07-21       Impact factor: 5.606

5.  Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension.

Authors:  Alberto Lo Gullo; Giuseppe Mandraffino; Javier Rodríguez-Carrio; Michele Scuruchi; Davide Sinicropi; Maria Postorino; Carmela Morace; Clemente Giuffrida; Davide Sciortino; Romina Gallizzi; Saverio Loddo; Concetta Zito; Giovanni Squadrito
Journal:  Biomedicines       Date:  2021-05-11

Review 6.  Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.

Authors:  Saja Almaaitah; Kristin B Highland; Adriano R Tonelli
Journal:  Integr Blood Press Control       Date:  2020-03-23

7.  Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study).

Authors:  Zixuan Pan; Alberto M Marra; Nicola Benjamin; Christina A Eichstaedt; Norbert Blank; Eduardo Bossone; Antonio Cittadini; Gerry Coghlan; Christopher P Denton; Oliver Distler; Benjamin Egenlauf; Christine Fischer; Satenik Harutyunova; Panagiota Xanthouli; Hanns-Martin Lorenz; Ekkehard Grünig
Journal:  Arthritis Res Ther       Date:  2019-10-26       Impact factor: 5.156

Review 8.  Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review.

Authors:  Katarina Zeder; Chiara Banfi; Gregor Steinrisser-Allex; Bradley A Maron; Marc Humbert; Gregory D Lewis; Andrea Berghold; Horst Olschewski; Gabor Kovacs
Journal:  Eur Respir J       Date:  2022-10-13       Impact factor: 33.795

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.